Overview

Dexamethasone in Total Knee Arthroplasty

Status:
Recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the most efficacious and safest dexamethasone dose given intraoperatively during total knee arthroplasty that reduces postoperative opioid consumption and pain, improves postoperative nausea and vomiting, and minimizes postoperative complications.
Phase:
Phase 4
Details
Lead Sponsor:
Rush University Medical Center
Treatments:
BB 1101
Dexamethasone
Dexamethasone acetate